+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-06-11Number of Pages: 123

Healthcare CMO Market (Service - Pharmaceutical Contract Manufacturing Services (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Form (FDF) Manufacturing, and Packaging) and Medical Device Contract Manufacturing Services (Outsourcing Design, Device Manufacturing (Material Process Services, Electronic Manufacturing Services, and Finished Products), and Final Goods Assembly) - Global Industry Analysis, Size, Share, Trends, Growth and Forecast 2013 - 2019

In the global pharmaceutical and biotechnology industry, outsourcing market represents one of the fastest growing markets and contract manufacturing of pharmaceutical and medical devices occupies a significant portion in the overall outsourcing market. In the past, pharmaceutical and medical device industry has maintained a low level of outsourcing due to several concerns such as product quality, delay in delivery, regulatory compliance and intellectual property protection rights. However, in recent years, outsourcing strategy has become more striking, as the pharmaceutical and medical device companies are looking for various strategic options to reduce cost, improve product portfolio, reduce the time to market and improve efficiencies. Along with these, economic burden, increased financial crisis and technological advances are the other factors that have compelled pharmaceutical, biotechnology and life science companies to outsource their manufacturing processes in order to achieve their cost benefits and save time. 
 
The global healthcare CMO market is segmented into pharmaceutical contract manufacturing services and medical devices contract manufacturing services. Further, the pharmaceutical contract manufacturing services segment is classified as API (active pharmaceutical ingredients) manufacturing, FDF (final dosage formulations) manufacturing and packaging. Among these, contract FDF manufacturing segment is expected to experience a healthy growth rate during the forecast period of 2013 to 2019, due to the rise demand for generic drugs and increasing R&D investment by life sciences companies. In addition, rise in number of blockbuster drugs going off-patent and increased adoption of novel technologies are further boosting the growth of this market. Similarly, medical devices contract manufacturing services segment is further categorized into design outsourcing, device manufacturing and final goods assembly. Among these afore-mentioned services, the market for medical device contract manufacturing accounted for largest market share (87.7%) in 2012 and is expected to grow at an attractive growth rate during the forecast period of 2013 to 2019.
 
Geographically, North America constituted the largest market in the global healthcare CMO market in 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of 17.8% from 2013 to 2019. This growth has been attributed to favorable government regulations, improved intellectual property protection rights and increased adoption of novel technologies. In addition, tax benefits, low labor costs and other overheads and availability of skilled professionals at a very low cost compared to developed nations would trigger the growth of this market in Asia-Pacific region.
 
The major players of this market are Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Lonza Group, Patheon, Inc., Piramal Healthcare, Accellent, Symmetry Medical, Inc., Greatbatch, Inc., Memry Corporation, Teleflex MedOEM, Admedes Schuessler and Donatelle.

 
Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Healthcare CMO Market (2012 & 2019)
2.2 Global Healthcare CMO Market, by Service Type, 2012 (USD Billion)
2.3 Global Pharmaceutical Contract Manufacturing Market, by Service Type, 2012 (USD Billion)
2.4 Global Medical Device Contract Manufacturing Market, by Service Type,  2012 (USD Billion)
2.5 Comparative Analysis: Global Healthcare CMO Market, by Geography, 2012 and 2019 (Value %)
 
Chapter 3 Market Overview
3.1 Introduction
3.2 Market Dynamics
      3.2.1 Market Drivers
               3.2.1.1 Patent expirations of drugs are assisting the growth of global CMO industry
                          3.2.1.1.1 List of top brands with patent expirations
               3.2.1.2 Restructuring of pharmaceutical and medical device manufacturing activities augmenting the growth of CMOs market
               3.2.1.3 Increasing trend of outsourcing manufacturing activities from high to low cost regions
               3.2.1.4 Outsourcing to maximize revenue by reducing time to market
      3.2.2 Market Restraints
               3.2.2.1 Quality concerns and non-compliance of regulatory requirements hamper the growth of CMOs market
               3.2.2.2 Failure to deliver on-time supplies
      3.2.3 Opportunities
               3.2.3.1 Biologics
               3.2.3.2 Emerging markets
3.3 Porters Five Forces Analysis: Global Healthcare CMO Market
      3.3.1 Bargaining Power of Suppliers
      3.3.2 Bargaining Power of Buyers
      3.3.3 Threat of New Entrants
      3.3.4 Threat of Substitutes
      3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis: Global Healthcare CMO Market, by Geography
3.5 Heat Map Analysis: Medical Devices Contract Manufacturing Market, by Key Market Players
      3.5.1 Heat Map Analysis: Key Market Players for the Medical Devices Contract Manufacturing Market
3.6 Market Share Analysis: Global Pharmaceutical Contract Manufacturing Market, by Key Players, 2012 (Value %)
 
Chapter 4 Global Healthcare CMO Market, by Service Type
4.1 Introduction
      4.1.1 Global Healthcare CMO Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
4.2 Pharmaceutical Contract Manufacturing Services
      4.2.1 Global Pharmaceutical Contract Manufacturing Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
      4.2.2 Active Pharmaceutical Ingredients (API) Manufacturing
               4.2.2.1 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
      4.2.3 Final Dosage Form (FDF) Manufacturing
               4.2.3.1 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
               4.2.3.2 Solid Dose Formulations
                          4.2.3.2.1 Global Solid Dose Formulations Contract Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
               4.2.3.3 Semi-solid and Liquid Dose Formulations
                          4.2.3.3.1 Global Semi-solid and Liquid Dose Formulations Contract Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
              4.2.3.4 Injectable Dose Formulations
                          4.2.3.4.1 Global Injectable Dose Formulations Contract Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
      4.2.4 Packaging
              4.2.4.1. Global Contract Packaging Market Revenue, 2011 – 2019 (USD Billion)
4.3 Medical Device Contract Manufacturing Services
      4.3.1 Global Medical Device Contract Manufacturing Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
      4.3.2 Outsourcing Design
              4.3.2.1 Global Medical Device Design Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
      4.3.3 Device Manufacturing
              4.3.3.1 Global Device Contract Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
              4.3.3.2 Material Process Services
                         4.3.3.2.1 Global Contract Material Process Services Market Revenue, 2011 – 2019 (USD Billion)
              4.3.3.3 Electronic Manufacturing Services
                         4.3.3.3.1 Global Contract Electronic Manufacturing Services Market Revenue, 2011 – 2019 (USD Billion)
              4.3.3.4 Finished Products
                         4.3.3.4.1 Global Contract Finished Products Manufacturing Services Market Revenue, 2011 – 2019 (USD Billion)
      4.3.4 Final Goods Assembly
              4.3.4.1 Global Contract Final Goods Assembly Services Market Revenue, 2011 – 2019 (USD Billion)
 
Chapter 5 Global Healthcare CMO Market, by Geography
5.1 Overview
      5.1.1 Global Contract Manufacturing Organizations (CMO) Market Revenue, by Geography, 2011 – 2019 (USD Billion)
5.2 North America
      5.2.1 North America Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
      5.2.2 North America Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
      5.2.3 North America Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
5.3 Europe
      5.3.1 Europe Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
      5.3.2 Europe Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
      5.3.3 Europe Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
5.4 Asia Pacific
      5.4.1 Asia-Pacific Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
      5.4.2 Asia-Pacific Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
      5.4.3 Asia-Pacific Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
5.5 RoW
      5.5.1 RoW Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
      5.5.2 RoW Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
      5.5.3 RoW Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
 
Chapter 6 Recommendations
6.1 Success Strategies
      6.1.1 Expand Market in Emerging Countries
      6.1.2 Timely Entry in the Market
      6.1.3 Offer Wide Range of Manufacturing Services
      6.1.4 Developing Strategic Alliances and Partnerships with Pharmaceutical Companies
      6.1.5 Ensure Product Quality, Data Confidentiality and Regulatory Compliance
 
Chapter 7 Company Profiles
7.1 Accellent, Inc.
      7.1.1 Company Overview
      7.1.2 Financial Overview
      7.1.3 Product Portfolio
      7.1.4 Business Strategies
               7.1.4.1 Strategic acquisition
               7.1.4.2 Geographical expansion
      7.1.5 Recent Developments
7.2 Boehringer Ingelheim GmbH
      7.2.1 Company Overview
      7.2.2 Financial Overview
      7.2.3 Product Portfolio
      7.2.4 Business Strategies
               7.2.4.1 Research and development for medical innovation
      7.2.5 Recent Developments
7.3 Catalent Pharma Solutions, Inc.
      7.3.1 Company Overview
      7.3.2 Financial Overview
      7.3.3 Product Portfolio
      7.3.4 Business Strategies
               7.3.4.1 Geographical expansion of business
               7.3.4.2 Diversification of product portfolio
      7.3.5 Recent Developments
7.4 DSM
      7.4.1 Company Overview
      7.4.2 Financial Overview
      7.4.3 Product Portfolio
      7.4.4 Business Strategies
               7.4.4.1 Strategic acquisitions
      7.4.5 Recent Developments
7.5 Fareva
      7.5.1 Company Overview
      7.5.2 Financial Overview
      7.5.3 Product Portfolio
      7.5.4 Business Strategies
               7.5.4.1 Extensive product portfolio
               7.5.4.2 Safety environment for staff
               7.5.4.3 Commitment to quality
      7.5.5 Recent Developments
7.6 Greatbatch, Inc.
      7.6.1 Company Overview
      7.6.2 Financial Overview
      7.6.3 Product Portfolio
      7.6.4 Business Strategies
               7.6.4.1 Research and development
               7.6.4.2 Patents and proprietary technology
               7.6.4.3 Mergers and acquisitions
      7.6.5 Recent Developments
7.7 Lonza Group
      7.7.1 Company Overview
      7.7.2 Financial Overview
      7.7.3 Product Portfolio
      7.7.4 Business Strategies
               7.7.4.1 Investment in emerging economies
               7.7.4.2 Mergers and acquisitions
      7.7.5 Recent Developments
7.8 Patheon, Inc.
      7.8.1 Company Overview
      7.8.2 Financial Overview
      7.8.3 Product Portfolio
      7.8.4 Business Strategies
               7.8.4.1 Strategic acquisitions
               7.8.4.2 Geographical expansion of business
      7.8.5 Recent Developments
7.9 Piramal Healthcare
      7.9.1 Company Overview
      7.9.2 Financial Overview
      7.9.3 Product Portfolio
      7.9.4 Business Strategies
               7.9.4.1 Expansion of services offered
      7.9.5 Recent Developments
7.11 Symmetry Medical, Inc.
      7.11.1 Company Overview
      7.11.2 Financial Overview
      7.11.3 Product Portfolio
      7.11.4 Business Strategies
                 7.11.4.1 Diversification of product portfolio
                 7.11.4.2 Robust research and development activities
      7.11.5 Recent Developments

List of Figures
 
FIG. 1 Global Healthcare CMO Market Segmentation
FIG. 2 Global Healthcare CMO Market, by Service Type, 2012 (USD Billion)
FIG. 3 Global Pharmaceutical Contract Manufacturing Market, by Service Type, 2012 (USD Billion)
FIG. 4 Global Medical Device Contract Manufacturing Market, by Service Type, 2012 (USD Billion)
FIG. 5 Comparative Analysis: Global Healthcare CMO Market, by Geography, 2012 and 2019 (Value %)
FIG. 6 Global Healthcare CMO Market: Drivers and Restraints
FIG. 7 Porter’s Five Force Analysis: Global Healthcare CMO Market
FIG. 8 Market Attractiveness Analysis: Global Healthcare CMO Market, 2012, by Geography
FIG. 9 Heat Map Analysis: Key Market Players for the Medical Devices Contract Manufacturing Market
FIG. 10 Market Share Analysis: Global Pharmaceutical Contract Manufacturing Market, by Key Players, 2012 (Value %)
FIG. 11 Global Contract API (Active Pharmaceutical Ingredients) Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 12 Global Contract FDF (Finished Dosage Formulation) Development and Manufacturing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 13 Global Solid Dose Formulations Contract Manufacturing  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 14 Global Semi-solid and Liquid Dose Formulations Contract Manufacturing  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 15 Global Injectable Dose Formulations Contract Manufacturing  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 16 Global Contract Packaging Market Revenue, 2011 – 2019 (USD Billion)
FIG. 17 Global Medical Device Design Outsourcing Market Revenue, 2011 – 2019 (USD Billion)
FIG. 18 Global Device Contract Manufacturing  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 19 Global Contract Material Process Services  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 20 Global Contract Electronic Manufacturing Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 21 Global Contract Finished Products Manufacturing Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 22 Global Contract Final Goods Assembly Services  Market Revenue, 2011 – 2019 (USD Billion)
FIG. 23 North America Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
FIG. 24 North America Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 25 North America Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 26 Europe Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
FIG. 27 Europe Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 28 Europe Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 29 Asia-Pacific Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
FIG. 30 Asia-Pacific Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 31 Asia-Pacific Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 32 RoW Healthcare CMO Market Revenue, 2011 – 2019 (USD Billion)
FIG. 33 RoW Healthcare CMO Market Revenue for Pharmaceutical Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 34 RoW Healthcare CMO Market Revenue for Medical Device Contract Manufacturing Services, 2011 – 2019 (USD Billion)
FIG. 35 Accellent, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 36 Boehringer Ingelheim GmbH: Annual Revenue, 2010– 2012 (USD Million)
FIG. 37 Catalent Pharma Solutions, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 38 DSM: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 39 Greatbatch, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 40 Lonza Group: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 41 Patheon, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 42 Piramal Healthcare: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 43 Symmetry Medical, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables
 
TABLE 1 Market Snapshot: Healthcare CMO Market
TABLE 2 Global Healthcare CMO Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
TABLE 3 Global Pharmaceutical Contract Manufacturing Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
TABLE 4 Global Medical Device Contract Manufacturing Market Revenue, by Service Type, 2011 – 2019 (USD Billion)
TABLE 5 Global Contract Manufacturing Organizations (CMO) Market, by Geography, Revenue, 2011 – 2019 (USD Billion)

Global Healthcare CMO Market: Overview

A majority of medical devices and pharmaceutical manufacturing companies around the world are gradually outsourcing their production activities to contract manufacturers to achieve cost efficiency and focus on their core competencies. Through this, the companies are aiming to capitalize on specific expertise in a given business category, which may not be available in house. The trend is thus expected to bolster opportunities for the global healthcare contract manufacturing outsourcing (CMO) market. 

The report studies the global healthcare CMO market based on services and its regional segments. By service, the market is bifurcated into medical device CMO services and pharmaceutical CMO services. Of these, the pharmaceutical CMO services segment led the market with a share of 55.4% in 2012. 

It presents a holistic overview of the global healthcare CMO market, covering drivers and restraints affecting its trajectory and various market segments. The report is aimed at providing better perspective about the global healthcare CMO market to the stakeholders hence it studies in detail the various factors affecting its growth across the key segments. Besides this, it identifies lucrative opportunities across key regional segments. 

Global Healthcare CMO Market: Trends and Opportunities 

Contract manufacturing outsourcing involves certain manufacturing activities that were previously executed by the producers. Despite being an emerging trend, the technology has taken over the healthcare industry by storm, with leading players outsourcing their manufacturing activities to contract manufacturers with an intent of reducing cost incurred on production without compromising on the product quality. The practice also helps these companies capitalize on the expertise of contract manufacturers, while concentrating on their core activities at the same time.

As per the report, the market is considerably gaining from the presence of a skilled workforce at a lower cost in emerging economies, encouraged by which healthcare companies are outsourcing certain manufacturing activities. Therefore, efforts taken by pharmaceutical and medical devices companies to restructure their manufacturing processes alongside other activities involved in the production of medical devices have strengthened the global contract manufacturing market in the healthcare industry. 

Global Healthcare CMO Market: Regional Outlook 

Regionally, Europe, North America, Asia Pacific, and Rest of the World constitute the key segments in the global healthcare CMO market. Of these, the dominance was enjoyed by North America as it occupied overall the largest share in 2012. However, the healthcare CMO market is expected to record highest growth in Asia Pacific at a CAGR of 17.80% between 2013 and 2019. 

The implementation of favorable government regulations and amendments in intellectual property protection right are the chief drivers that will boost the Asia Pacific healthcare CMO market on a legislative front. Besides these, the market is also expected to gain from the rising uptake of novel technologies in the region. Labor cost in Asia Pacific is considerably low, which during the forecast period is likely to aid the expansion of the healthcare CMO market in the region. 

Global Healthcare CMO Market: Vendor Landscape 

Piramal Healthcare, Symmetry Medical Inc., Fareva, Greatbatch Inc., Patheon Inc., Boehringer Ingelheim GmbH, Accellent Inc., Lonza Group, Catalent Pharma Solutions Inc., and DSM are some of the major companies operating in the global healthcare CMO market. Their solutions and services they offer are recognized and widely acknowledged as the most prominent ones around the world. The report therefore presents a detailed assessment of marketing strategies they adopted over the years and the impact of the same on the overall market. It includes a detailed profiles of these companies and conducts SWOT analysis to study their strengths and weaknesses and present insight into opportunities and threats that these companies may witness in the forecast period. 

The global healthcare CMO market is segmented into: 

By Service Type 

  • Pharmaceutical Contract Manufacturing Services
  • Active Pharmaceutical Ingredients (API) Manufacturing
  • Final Dosage Form (FDF) Manufacturing
  • Packaging 
  • Medical Device Contract Manufacturing Services
  • Outsourcing Design
  • Device Manufacturing (Material Process Services, Electronic Manufacturing Services, and Finished Products)
  • Final Goods Assembly 

Geographies analyzed under this research report include 

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa 

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years 

Key highlights of this report 

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments


 
 
Back To Top